Literature DB >> 29101000

What is precise pathophysiology in development of hypertension in pregnancy? Precision medicine requires precise physiology and pathophysiology.

Qinqin Gao1, Jiaqi Tang1, Na Li1, Bailin Liu1, Mengshu Zhang1, Miao Sun2, Zhice Xu3.   

Abstract

It is widely accepted that placental ischemia is central in the evolution of hypertension in pregnancy. Many studies and reviews have targeted placental ischemia to explain mechanisms for initiating pregnancy hypertension. The placenta is rich in blood vessels, which are the basis for developing placental ischemia. However, is the physiology of placental vessels the same as that of nonplacental vessels? What is the pathophysiology of placental vessels in development of pregnancy hypertension? This review aims to provide a comprehensive summary of special features of placental vascular regulations and the pathophysiological changes linked to preeclamptic conditions. Interestingly, some popular theories or accepted concepts could be based on our limited knowledge and evidence regarding placental vascular physiology, pharmacology and pathophysiology. New views raised could offer interesting ideas for future investigation of mechanisms as well as targets for pregnancy hypertension.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29101000     DOI: 10.1016/j.drudis.2017.10.021

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  5 in total

Review 1.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

2.  DNA methylation-reprogrammed oxytocin receptor underlies insensitivity to oxytocin in pre-eclamptic placental vasculature.

Authors:  Xiaorong Fan; Ting Xu; Hongmei Ding; Huan Li; Yuxian Yang; Yun He; Jiaqi Tang; Yanping Liu; Xueyi Chen; Jie Chen; Jianying Tao; Zhice Xu; Qinqin Gao
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

3.  Promoter methylation changes and vascular dysfunction in pre-eclamptic umbilical vein.

Authors:  Qinqin Gao; Xiaorong Fan; Ting Xu; Huan Li; Yun He; Yuxian Yang; Jie Chen; Hongmei Ding; Jianying Tao; Zhice Xu
Journal:  Clin Epigenetics       Date:  2019-05-28       Impact factor: 6.551

4.  Protein tyrosine phosphatase receptor type O (PTPRO) knockdown enhances the proliferative, invasive and angiogenic activities of trophoblast cells by suppressing ER resident protein 44 (ERp44) expression in preeclampsia.

Authors:  Yang Yang; Xiaoxia Qiu; Fang Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Research progress of placental vascular pathophysiological changes in pregnancy-induced hypertension and gestational diabetes mellitus.

Authors:  Jiahui Lei; Meng Zhao; Lingjun Li; Bingyu Ji; Ting Xu; Miao Sun; Jie Chen; Junlan Qiu; Qinqin Gao
Journal:  Front Physiol       Date:  2022-07-19       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.